Leisure Acquisition

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch LACQ and buy or sell other stocks, ETFs, and their options commission-free!

About LACQ

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. 

CEO
D. Lynn Kirkpatrick, PhD
CEOD. Lynn Kirkpatrick, PhD
Employees
9
Employees9
Headquarters
La Jolla, California
HeadquartersLa Jolla, California
Founded
2003
Founded2003
Employees
9
Employees9

LACQ Key Statistics

Market cap
23.83M
Market cap23.83M
Price-Earnings ratio
-0.36
Price-Earnings ratio-0.36
Dividend yield
Dividend yield
Average volume
36.73K
Average volume36.73K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$14.67
52 Week high$14.67
52 Week low
$1.62
52 Week low$1.62

People also own

Based on the portfolios of people who own LACQ. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.